Cost analysis of remifentanil and fentanyl for neurosurgical anesthesia

American Journal of Health-System Pharmacy

Volumn 56, Issue 6, 1999, Pages 551-554

  Hogue, Susan ^a   Reese, Pat Ray ^b   Munshi, Onita ^c   Young, Terri ^c  

^a GLAXOSMITHKLINE   (United States)

^b Strategic Outcomes Services Inc   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIHYPERTENSIVE AGENT; CARDIOVASCULAR AGENT; ELECTROLYTE; FENTANYL; HYPNOTIC AGENT; INFUSION FLUID; ISOFLURANE; NEUROMUSCULAR BLOCKING AGENT; NITROUS OXIDE; OPIATE AGONIST; PANCURONIUM BROMIDE; PLASMA SUBSTITUTE; REMIFENTANIL; SEDATIVE AGENT; THIOPENTAL; FENTANYL CITRATE; HYPERTENSIVE AGENT; HYPNOTIC SEDATIVE AGENT;

ANESTHESIA; BRAIN TUMOR; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRANIOTOMY; DRUG COST; HUMAN; MAJOR CLINICAL STUDY; NEUROSURGERY; NOTE; PRIORITY JOURNAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; MULTICENTER STUDY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY;

EID: 0343238141     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.6.551     Document Type: Note

References (10)

1. DeMonaco HJ, Shah AS. Economic considerations in the use of neuromuscular blocking drugs. J Clin Anesth. 1994; 6:383-7.
2. Ramspacher S, Hough J. 1996 IMS hospital pharmacy review: leading dollar volume pharmaceuticals. Hosp Pharm. 1997; 32:774-99.
3. Vietz TS. Principles of cost analysis. J Clin Anesth. 1994; 6:357-63.
4. Golembiewski JA. Cost-containment strategies for anesthesia drugs in the operating room: the University of Michigan Hospitals' experience. Drug Benefit Trends. 1997; 9(7):13-4.
5. Dexter F, Tinker JH. Analysis of strategies to decrease postanesthesia care unit costs. Anesthesiology. 1995; 82:94-101.
6. Johnstone RE, Martinec CL. Costs of anesthesia. Anesth Analg. 1993; 76:840-8.
7. Guy J, Hindman BJ, Baker KZ et al. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology. 1997; 86:514-24.
8. Garrett HM, ed. Red book. Montvale, NJ: Medical Economics; 1996.
9. Philip B. Practical cost-effective choices: ambulatory general anesthesia. J Clin Anesth. 1995; 7:606-13.
10. Carrasco G, Molina R, Costa J et al. Propofol vs. midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis. Chest. 1993; 103:557-654.